findmyKOL

Clark Tsai, MD

Basic profile

University of California San Diego

ORCIDNone on fileNPI↗
✓ Full record
RegionConcord, CA · WestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Clark Tsai is an Ophthalmology physician affiliated with University of California San Diego. OpenAlex indexes 21 publications with 698 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
21publications

Distinct works indexed by OpenAlex.

698citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2700 Grant St
Ste. 100
Concord, CA 945202266

Telephone

925-689-7744

Registry record last updated 17 Aug 2015.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    68.4%
    Prostaglandin Analog35.5%
    Latanoprost96%Lumigan2%Travoprost1%Zioptan1%
    Part D<11 patients
    alpha-Adrenergic Agonist16.4%
    Brimonidine Tartrate92%Brimonidine Tartrate-Timolol5%Alphagan P2%Combigan1%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    11.2%
    Beta blocker11.2%
    Timolol Maleate100%
    Part D<11 patients
  • Anti-infectives

    6.6%
    Fluoroquinolone Antibacterial6.3%
    Moxifloxacin100%
    Part D≥219 patients
    Macrolide0.3%
    Erythromycin100%
    Part D≥19 patients
Where care is delivered (Part B)2.4% facility · 97.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”